|Articles|August 25, 2021

CluePoints and ZS RBQM Partnership

CluePoints has partnered with ZS to offer capabilities in portfolio-level performance oversight. The new partnership pairs a solutions company focused on study-level risk-based management with a pharmaceutical and biotech solutions provider with capabilities in portfolio-level quality and operational oversight. The partnership also offers consulting from a wider pool of subject matter experts.

More on the RBQM offering

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Lab orchestration is often reduced to scheduling and automation, but a connected scientific record across the physical, logical, and digital domains is what actually makes AI-ready research possible. Credit: Stock.Adobe.com/VStudio.

Lab Orchestration Is Not What You Think It Is

ByRyan Bernhardt

September 11th 2026

Why Seizure Counts Alone Can't Define Success in Epilepsy Trials

ByAmélie Lothe,Andy Studna, Senior Editor

September 11th 2026

ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative

ByAndy Studna, Senior Editor

September 11th 2026

Recruitment in the Age of AI: Q&A with John Worden, Javara

ByJohn Worden,Andy Studna, Senior Editor

September 10th 2026

What It Actually Means to Embed the Patient Voice in Trial Design

ByAmélie Lothe,Andy Studna, Senior Editor

September 10th 2026

Trending on Applied Clinical Trials Online

Recruitment in the Age of AI: Q&A with John Worden, Javara

Why Seizure Counts Alone Can't Define Success in Epilepsy Trials

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

Lab Orchestration Is Not What You Think It Is

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale